Filing Flows › Fennec Pharmaceuticals (FENC) › How it makes money
How Fennec Pharmaceuticals (FENC) makes money
Fennec Pharmaceuticals (FENC) made $17.9M of revenue in the second quarter 2026 (Q2 2026), +85% from a year earlier. PEDMARK product sales, net brought in $17.2M (96%); Other revenue brought in $710K (4%). Of every dollar of revenue, 10¢ was left as operating profit, 11¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| PEDMARK product sales, net | $17.2M | 96.0% | — | +78% |
| Other revenue | $710K | 4.0% | — | — |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $17.9M | 100.0% |
| Operating profit | $1.7M | 9.7% |
| Income tax | $42K | 0.2% |
| Net earnings | $2.0M | 11.0% |
| Operating cash flow | $50K | 0.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $17.9M | +85% |
| Q1 2026 | $15.1M | +73% |
| Q4 2025 | $13.8M | +74% |
| Q3 2025 | $12.5M | +79% |
| Q2 2025 | $9.7M | +33% |
| Q1 2025 | $8.8M | -66% |
| Q4 2024 | $7.9M | -19% |
From Fennec Pharmaceuticals' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Fennec Pharmaceuticals make money?
Fennec Pharmaceuticals (FENC) made $17.9M of revenue in the second quarter 2026 (Q2 2026), +85% from a year earlier. PEDMARK product sales, net brought in $17.2M (96%); Other revenue brought in $710K (4%). Of every dollar of revenue, 10¢ was left as operating profit, 11¢ was left as net earnings.
What is Fennec Pharmaceuticals' biggest business?
PEDMARK product sales, net: $17.2M in the second quarter 2026, 96% of revenue, +78% from a year earlier.
What is Fennec Pharmaceuticals' profit margin?
Net earnings were $2.0M, 11.0% of revenue, in the second quarter 2026; the operating margin was 9.7%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.